Free Account Opening + AMC Free Demat
Loading...

Arrowhead Seperation Engineering IPO vs Sunrest Lifescience IPO

Comparision between Arrowhead Seperation Engineering IPO and Sunrest Lifescience IPO.

IPO Details

Arrowhead Seperation Engineering IPO is a SME Fixed Price Issue IPO proposed to list at BSE SME while Sunrest Lifescience IPO is a SME Fixed Price Issue proposed to list at NSE SME.

  Arrowhead Seperation Engineering IPO Sunrest Lifescience IPO
Logo Arrowhead Seperation Engineering IPO Logo Sunrest Lifescience IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Fixed Price Issue Fixed Price Issue
Listing At BSE SME NSE SME
Lead Managers Aryaman Financial Services Limited Mark Corporate Advisors Private Limited
Registrar Cameo Corporate Services Limited Skyline Financial Services Private Ltd
Market Maker Aryaman Capital Markets Limited Svcm Securities Private Limited
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Arrowhead Seperation Engineering IPO is up to ₹13.00 Cr whereas the issue size of the Sunrest Lifescience IPO is up to ₹10.85 Cr. The final issue price of Arrowhead Seperation Engineering IPO is ₹233.00 per share and of Sunrest Lifescience IPO is ₹84.00 per share.

  Arrowhead Seperation Engineering IPO Sunrest Lifescience IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final) ₹233.00 per share ₹84.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 600 shares 1600 shares
Fresh Issue Size 5,58,000 shares 12,91,200 shares
Fresh Issue Size (Amount) up to ₹13.00 Cr up to ₹10.85 Cr
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 5,58,000 shares 12,91,200 shares
Issue Size Total (Amount) up to ₹13.00 Cr up to ₹10.85 Cr

IPO Timetable

Arrowhead Seperation Engineering IPO opens on Nov 16, 2023, while Sunrest Lifescience IPO opens on Nov 07, 2023. The closing date of Arrowhead Seperation Engineering IPO and Sunrest Lifescience IPO is Nov 20, 2023, and Nov 09, 2023, respectively.

  Arrowhead Seperation Engineering IPO Sunrest Lifescience IPO
Anchor Bid Date
Issue Open Nov 16, 2023 Nov 07, 2023
Issue Close Nov 20, 2023 Nov 09, 2023
Basis Of Allotment (Tentative) Nov 23, 2023 Nov 15, 2023
Initiation of Refunds (Tentative) Nov 24, 2023 Nov 16, 2023
Credit of Share (Tentative) Nov 28, 2023 Nov 17, 2023
Listing date (Tentative) Nov 28, 2023 Nov 20, 2023
Anchor Lockin End date 1 Dec 23, 2023 Dec 15, 2023
Anchor Lockin End date 2 Feb 21, 2024 Feb 13, 2024

Financials

Arrowhead Seperation Engineering IPO P/E ratio is 18.09, as compared to Sunrest Lifescience IPO P/E ratio of 12.33.

  Arrowhead Seperation Engineering IPO Sunrest Lifescience IPO
Financial

Arrowhead Seperation Engineering Limited Financial Information (Restated)

Arrowhead Seperation Engineering Limited's revenue increased by 98.91% and profit after tax (PAT) rose by 1744.93% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended30 Jun 202331 Mar 202331 Mar 202231 Mar 2021
Assets2,180.622,070.531,832.231,567.43
Revenue881.712,171.571,091.73916.63
Profit After Tax64.34169.189.17-179.19
Net Worth310.41246.0777.2668.09
Reserves and Surplus179.08114.74-3.56-12.73
Total Borrowing896.02812.67699.45600.59
Amount in ₹ Lakhs

Sunrest Lifescience Limited Financial Information (Restated)

Sunrest Lifescience Limited's revenue decreased by -8.32% and profit after tax (PAT) rose by 162.91% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended30 Jun 202331 Mar 202331 Mar 202231 Mar 2021
Assets1,706.281,671.371,301.97948.15
Revenue563.582,467.052,690.991,694.91
Profit After Tax75.08204.3177.7116.55
Net Worth386.60311.52107.2029.49
Reserves and Surplus86.6011.52106.2028.49
Total Borrowing347.32214.32323.83231.55
Amount in ₹ Lakhs
Promoter Shareholding (Pre-Issue) 50% 100%
Promoter Shareholding (Post-Issue) 35.09% 69.91%
P/E Ratio 18.09 12.33
Market Cap ₹43.60 Cr. ₹36.05 Cr.
ROE 105%% 53%%
ROCE 30.94%% 98%%
Debt/Equity 3.3 0.64
EPS ₹12.88 ₹6.81
RoNW 68.75%% 65.59%%

Shares Offered

In the Arrowhead Seperation Engineering IPO retail investors (RII) are offered 2,64,000 shares while in Sunrest Lifescience IPO retail investors are offered 2,64,000 shares. Qualified institutional buyers (QIB) are offered 0 shares in Arrowhead Seperation Engineering IPO and 0 shares in Sunrest Lifescience IPO.

  Arrowhead Seperation Engineering IPO Sunrest Lifescience IPO
Anchor Investor Reserveration
Market Maker Reserveration 30,000 shares 65,600 shares
QIB 0 shares 0 shares
NII 2,64,000 shares 6,12,800 shares
RII 2,64,000 shares 6,12,800 shares
Employee 0 shares 0 shares
Others
Total 5,28,000 shares 12,25,600 shares

Bids Received (Subscription)

Arrowhead Seperation Engineering IPO subscribed 94.79x in total, whereas Sunrest Lifescience IPO subscribed 48.54x.

  Arrowhead Seperation Engineering IPO Sunrest Lifescience IPO
QIB (times)
NII (times) 46.02x 29.17x
Big NII (times)
Small NII (times)
RII (times) 142.30x 65.74x
Employee (times)
Other (times)
Total (times) 94.79x 48.54x

Comments

Add a public comment...